INVITRO AND INVIVO EFFECTS OF SM-10661, A NEWLY SYNTHESIZED PLATELET-ACTIVATING FACTOR(PAF) ANTAGONIST

被引：7
|
作者：
MOROOKA, S [1 ]
KOMURO, Y [1 ]
ANDO, R [1 ]
UCHIDA, M [1 ]
机构：
[1] SUMITOMO PHARMACEUT CO LTD,RES LABS,KONOHANA KU,OSAKA 554,JAPAN
来源：
PROSTAGLANDINS | 1988年 / 35卷 / 05期
关键词：
D O I：
10.1016/0090-6980(88)90243-2
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：840 / 840
页数：1
相关论文
共 50 条
  • [1] BIOLOGICAL EFFECT OF ORALLY ACTIVE PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST SM-10661
    KOMURO, Y
    IMANISHI, N
    UCHIDA, M
    MOROOKA, S
    MOLECULAR PHARMACOLOGY, 1990, 38 (03) : 378 - 384
  • [2] Prevention of cyclosporin nephrotoxicity with a platelet-activating factor (PAF) antagonist
    Bagnis, C
    Deray, G
    Dubois, M
    Pirotzky, E
    Jacquiaud, C
    Baghos, W
    Aupetit, B
    Braquet, P
    Jacobs, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (03) : 507 - 513
  • [3] Effects of intrastriatal injections of platelet-activating factor and the PAF antagonist BN 52021 on memory
    Packard, MG
    Teather, LA
    Bazan, NG
    NEUROBIOLOGY OF LEARNING AND MEMORY, 1996, 66 (02) : 176 - 182
  • [4] Topical application of a platelet-activating factor (PAF) antagonist in atopic dermatitis
    Abeck, D
    Andersson, T
    Grosshans, E
    Jablonska, S
    Kragballe, K
    Vahlquist, A
    Schmidt, T
    Dupuy, P
    Ring, J
    ACTA DERMATO-VENEREOLOGICA, 1997, 77 (06) : 449 - 451
  • [5] INVITRO HYPERRESPONSIVITY OF DIABETIC PLATELETS TO SATURATED PLATELET-ACTIVATING FACTOR (PAF)
    CACCIOLA, E
    GIUSTOLISI, R
    MUSSO, R
    MORRONE, ML
    GIUFFRIDA, G
    CACCIOLA, RR
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 107 - 107
  • [6] INTRACELLULAR RETENTION OF NEWLY SYNTHESIZED PLATELET-ACTIVATING FACTOR BY NEUTROPHILS
    LYNCH, JM
    HENSON, PM
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 1272 - 1272
  • [7] CHARACTERIZATION OF A PLATELET-ACTIVATING FACTOR RECEPTOR ANTAGONIST ISOLATED FROM HAIFENTENG (PIPER-FUTOKADSURA) - SPECIFIC-INHIBITION OF INVITRO AND INVIVO PLATELET-ACTIVATING FACTOR-INDUCED EFFECTS
    SHEN, TY
    HWANG, SB
    CHANG, MN
    DOEBBER, TW
    LAM, MHT
    WU, MS
    WANG, X
    HAN, GQ
    LI, RZ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (03) : 672 - 676
  • [8] RENAL MICROCIRCULATION DURING PLATELET-ACTIVATING FACTOR (PAF) ANTAGONIST (BN) ADMINISTRATION
    SANTOS, OFP
    BOIM, MA
    BREGMAN, R
    DRAIBE, SA
    SCHOR, N
    PROSTAGLANDINS, 1988, 35 (05): : 828 - 828
  • [9] PAF-ACETHER (PLATELET-ACTIVATING FACTOR)
    BENVENISTE, J
    ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1989, 19 : 355 - 358
  • [10] THE EFFECT OF PAF-RECEPTOR ANTAGONIST KADSURENONE ON THE CARDIOVASCULAR EFFECTS IN THE RABBIT INFUSED WITH SYNTHETIC PLATELET-ACTIVATING FACTOR (PAF)
    MONTRUCCHIO, G
    ALLOATTI, G
    MARIANO, F
    SHEN, TY
    TETTA, C
    RAGNI, R
    MEDA, E
    EMANUELLI, G
    CAMUSSI, G
    PROSTAGLANDINS, 1985, 30 (04): : 711 - 711
12345